DCM Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,168
Closed -$450K 66
2024
Q1
$450K Sell
5,168
-4,075
-44% -$348K 0.19% 52
2023
Q4
$761K Sell
9,243
-224
-2% -$17.1K 0.27% 53
2023
Q3
$742K Sell
9,467
-555
-6% -$46.5K 0.34% 48
2023
Q2
$883K Hold
10,022
0.38% 44
2023
Q1
$808K Sell
10,022
-60
-0.6% -$4.89K 0.38% 46
2022
Q4
$784K Sell
10,082
-714
-7% -$57.9K 0.38% 47
2022
Q3
$872K Buy
10,796
+1,584
+17% +$142K 0.44% 54
2022
Q2
$827K Buy
9,212
+473
+5% +$47.9K 0.36% 79
2022
Q1
$969K Sell
8,739
-249
-3% -$26.3K 0.34% 77
2021
Q4
$930K Buy
+8,988
New +$1.04M 0.27% 89

Other funds holding MDT

DCM Advisors's MDT Position: Q2 2024 in Review

DCM Advisors sold out of Medtronic (MDT) in Q2 2024, closing a stake of 5,168 shares — an estimated $450K sold.

DCM Advisors first reported a position in MDT in Q4 2021 and held it in 10 quarters. The position peaked at $969K in Q1 2022. 2,029 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • DCM Advisors reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • DCM Advisors sold 5,168 Medtronic shares in Q2 2024, an estimated $450K.
  • DCM Advisors first reported a position in Medtronic in Q4 2021 and held it in 10 quarters.
  • DCM Advisors's Medtronic position peaked at $969K in Q1 2022.
  • 2,029 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on DCM Advisors's 13F filing for Q2 2024, filed 15 Aug 2024.